| 0 (0%) | 09-27 09:34 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 10.57 | 1-year : | 12.35 |
| Resists | First : | 9.05 | Second : | 10.57 |
| Pivot price | 6.99  |
|||
| Supports | First : | 6.57 | Second : | 5.47 |
| MAs | MA(5) : | 6.78 |
MA(20) : | 7.43 |
| MA(100) : | 7.53 |
MA(250) : | 9.75 |
|
| MACD | MACD : | -0.6 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 6.9 |
D(3) : | 6 |
| RSI | RSI(14): 32.7 |
|||
| 52-week | High : | 16.73 | Low : | 5.28 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ WVE ] has closed above bottom band by 31.8%. Bollinger Bands are 45% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 6.93 - 6.98 | 6.98 - 7.02 |
| Low: | 6.48 - 6.53 | 6.53 - 6.58 |
| Close: | 6.73 - 6.8 | 6.8 - 6.87 |
Thu, 25 Sep 2025
Wave Life Sciences Highlights WVE-007 Obesity Treatment - TipRanks
Mon, 22 Sep 2025
WAVE Life Sciences Ltd. (NASDAQ:WVE) Receives $20.33 Average Price Target from Brokerages - MarketBeat
Sun, 14 Sep 2025
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely - simplywall.st
Fri, 12 Sep 2025
Wave Life Sciences is Now Oversold (WVE) - Nasdaq
Wed, 10 Sep 2025
Wave Life Sciences (WVE) Sees Promising Results From RestorAATion-2 Study - Yahoo Finance
Wed, 03 Sep 2025
New Analyst Forecast: $WVE Given $22.0 Price Target - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 159 (M) |
| Shares Float | 66 (M) |
| Held by Insiders | 15.7 (%) |
| Held by Institutions | 87 (%) |
| Shares Short | 17,320 (K) |
| Shares Short P.Month | 16,080 (K) |
| EPS | -0.81 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.88 |
| Profit Margin | -138.3 % |
| Operating Margin | -606.5 % |
| Return on Assets (ttm) | -39 % |
| Return on Equity (ttm) | -171.5 % |
| Qtrly Rev. Growth | -55.8 % |
| Gross Profit (p.s.) | -0.48 |
| Sales Per Share | 0.59 |
| EBITDA (p.s.) | -0.88 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -199 (M) |
| Levered Free Cash Flow | -148 (M) |
| PE Ratio | -8.5 |
| PEG Ratio | 0 |
| Price to Book value | 7.64 |
| Price to Sales | 11.52 |
| Price to Cash Flow | -5.44 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|